With opportunity and risk lurking in equal measure, today’s key considerations for biopharma startups when building their leadership teams and product go-to-market strategies are outlined.
Sarah Murchison
Advertisement
Managing Director, New Perspectives, Inc
Articles by Sarah Murchison
Advertisement
Latest Updated Articles
Startup Launch Guide: Avoiding 10 Common Pain PointsAugust 11th 2021
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
2
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
3
Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreement with Astellas Pharma
4
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.
5